Observational studyThe journal of headache and pain2025
Efficacy and continuability of 675 mg fremanezumab administration over 2 years.
Shohei Yoshida et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this paperpooled itcites it